skeleton
|
• bone marrow cells in vitro stimulated with rosiglitazone exhibit reduced differentiation into osteoclasts compared with similarly treated bone marrow cells from Ppargc1btm1.2Rev homozygotes
|
|
• mice are resistant to rosiglitazone-induced bone loss unlike Ppargc1btm1.2Rev homozygotes
|
immune system
|
• bone marrow cells in vitro stimulated with rosiglitazone exhibit reduced differentiation into osteoclasts compared with similarly treated bone marrow cells from Ppargc1btm1.2Rev homozygotes
|
hematopoietic system
|
• bone marrow cells in vitro stimulated with rosiglitazone exhibit reduced differentiation into osteoclasts compared with similarly treated bone marrow cells from Ppargc1btm1.2Rev homozygotes
|
cellular
|
• bone marrow cells in vitro stimulated with rosiglitazone exhibit reduced differentiation into osteoclasts compared with similarly treated bone marrow cells from Ppargc1btm1.2Rev homozygotes
|


Analysis Tools